|
661 MHRA warns of
more counterfeits in supply chain More
counterfeit medicines have been discovered in the UK supply chain
PJ 2007;278:661
Full Text
661 Pfizer purchasing quotas criticised
by CPS Some community pharmacy contractors
have had limits set by Pfizer on the amount they can order of certain
products, according to Community Pharmacy Scotland in its submission
to the Office of Fair Trading's market study into UK medicines distribution.
This issue has also been highlighed by the Pharmaceutical Services Negotiating
Committee
PJ 2007;278:661
Full Text
661 NHS in surplus by £510m The NHS has delivered a net surplus of £510m, according to unaudited results for 2006–07 published by the Department of Health this week
PJ 2007;278:661
Full Text
662 Call to raise pharmacy
profile in pandemic flu plans Pharmacy organisations
are calling for a higher profile for community pharmacy within the pandemic influenza
national framework and its supporting documents
PJ 2007;278:662
Full Text
662 Men's health DoH pharmacy scheme planned Community
pharmacists' role in improving men's access to health care is to be the subject
of a Department of Health project
PJ 2007;278:662
Full Text
662 First fellow of FPMM qualifies via new accreditation
process Peter Burrill, specialist public health
pharmaceutical adviser at Derbyshire County Primary Care Trust, has qualified
as the first fellow of the Faculty of Prescribing and Medicines Management within
the College of Pharmacy Practice
PJ 2007;278:662
Full Text
662 Welsh health minister appointed Edwina
Hart has been appointed Minister for Health and Social Services of the Welsh
Assembly Government
PJ 2007;278:662
Full Text
662 Alliance Boots takeover approved Alliance
Boots shareholders voted last week to approve the takeover of Alliance Boots
by AB Acquisitions, the company wholly owned by Stefano Pessina, executive deputy
chairman of Alliance Boots, and the private equity firm Kohlberg Kravis Roberts
PJ 2007;278:662
Full Text
662 NPA upgrades preregistration programme The
National Pharmacy Association is upgrading its preregistration training programme
to include residential courses and a conference
PJ 2007;278:662
Full Text
663 Manufacturer to offer
money back if treatment fails A refund scheme that
could allow bortezomib (Velcade) to be funded by the NHS to treat multiple myeloma
has been proposed by the drug's manufacturer Janssen-Cilag
PJ 2007;278:663
Full Text
663 Symbicort strategy approved for use in UK A new asthma management strategy for adults, which does not incorporate the use of a short-acting beta2 agonist, has been granted approval in the UK
PJ 2007;278:663
Full Text
663 Payments for next phase of Scottish contract
announced Pharmacy contractors in Scotland will
receive new Contract Preparation Payments this year to cover work required for
the next stage of their contract
PJ 2007;278:663
Full Text
664 Most paediatric cancer
drug errors reach patients before detection Errors
made when prescribing, preparing or administering paediatric cancer drugs often
reach the patient before being detected, with methotrexate being the drug most
commonly implicated, according to an epidemiological study published online
PJ 2007;278:664
Full Text
664 Safer packaging launched by Wockhardt Wockhardt
UK is introducing new medicines packs aimed at improving patient safety
PJ 2007;278:664
Full Text
664 Contact lens solution recall Complete
MoisturePlus contact lens solution is being recalled by manufacturer Advanced
Medical Optics (AMO) because of concerns over eye infections from Acanthamoeba
spp, which can cause serious corneal infections
PJ 2007;278:664
Full Text
664 Renal function project wins Pfizer preregistration
award How to determine renal function is the theme
of the winning project in this year's Pfizer Award for preregistration pharmacy
trainees in Scotland
PJ 2007;278:664
Full Text
665 Long-term trastuzumab
data show sustained benefit Trastuzumab (Herceptin)
achieves sustained reductions in breast cancer deaths and recurrence in women
with HER2 positive early breast cancer with no increase in risk of heart failure
over time. This finding comes from a long-term follow up of two major trials
reported at the American Society of Clinical Oncology annual meeting in Chicago
PJ 2007;278:665
Full Text
665 Progression-free survival doubled with bevacizumab
for advanced renal cell cancer Adding the angiogenesis
inhibitor bevacizumab (Avastin) to standard treatment for advanced renal cell
cancer doubles the length of progression-free survival, according to a trial
reported at the American Society of Clinical Oncology annual meeting in Chicago
PJ 2007;278:665
Full Text
665 Unannounced hygiene inspections to be carried
out at trusts The Healthcare Commission is to carry
out unannounced inspections at 120 NHS trusts over the coming year to check compliance
with the Government's hygiene code
PJ 2007;278:665
Full Text
665 Sertraline in minor depression Advanced
cancer patients with minor to moderate depression do not show any improvement
in symptoms, survival and well-being when treated with sertraline, a study published
online shows
PJ 2007;278:665
Full Text
665 Classifying toxicity A
new system for classifying the relative toxicity of different cancer treatments
has been proposed in an article published online
PJ 2007;278:665
Full Text
665 Lycopene and prostate cancer Lycopene
does not prevent prostate cancer, as has been suggested, say researchers. They
found no significant difference in blood lycopene levels among 28,000 men who
developed prostate cancer and those who did not
PJ 2007;278:665
Full Text
666 Folic acid supplements
can reduce risk of stroke Folic acid supplementation
can reduce the risk of stroke in those with no history of the disease, according
to research published
PJ 2007;278:666
Full Text
666 Head-to-head comparisons tend to favour
sponsors' drugs Head-to-head drug comparisons are
more likely to favour a trial sponsor's drug than its comparator, a study published
online this week has found
PJ 2007;278:666
Full Text
666 Control internet sales of pseudoephedrine
first, says PSNC Illegal internet sales of pseudoephedrine
should be controlled before interfering with the legitimate supply chain, the
Medicines and Healthcare products Regulatory Agency ahs been told
PJ 2007;278:666
Full Text
666 Routine iron supplements in pregnancy questioned Researchers
have called into question the suggestion that all women should take iron supplements
during pregnancy to reduce the risk of maternal anaemia leading to a low birth
weight baby
PJ 2007;278:666
Full Text |
The
Pharmaceutical Journal